Skip Navigation


International Immunology Advance Access originally published online on April 26, 2006
International Immunology 2006 18(6):967-979; doi:10.1093/intimm/dxl033
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
18/6/967    most recent
dxl033v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Quinn, A.
Right arrow Articles by Sercarz, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quinn, A.
Right arrow Articles by Sercarz, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2006. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

T cells to a dominant epitope of GAD65 express a public CDR3 motif

Anthony Quinn1, Marcia McInerney2, Donald Huffman3, Brigid McInerney3, Stella Mayo1, Kathryn Haskins4 and Eli Sercarz3,5,

1 Department of Biological Sciences, University of Toledo, 2801 West Bancroft Street, Toledo, OH 43606-3390, USA
2 Department of Medicinal and Biological Chemistry, University of Toledo, 2801 West Bancroft Street, Toledo, OH 43606-3390, USA
3 Division of Immune Regulation, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121, USA
4 Department of Immunology and Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, CO 80262, USA
5 Present address: Division of Immune Regulation, Torrey Pines Institute for Molecular Studies, San Diego, CA 92121, USA

Correspondence to: A. Quinn; E-mail: aquinn{at}utnet.utoledo.edu

Non-obese diabetic (NOD) mice spontaneously develop autoimmune diabetes, and serve as a model for type 1 diabetes (T1D) and natural autoimmunity. T cell responses to the pancreatic islet antigen glutamic acid decarboxylase 65 (GAD65) can be detected in the spleens of young prediabetic NOD mice, which display a unique MHC class II molecule. Here, we report that a distinct TcR ß chain and CDR3 motif are utilized by all NOD mice in response to a dominant determinant on GAD65, establishing a public repertoire in the spontaneous autoimmunity to an important islet cell antigen. GAD65 530–543 (p530)-reactive T cells preferentially utilize the Vß4, Dß2.1 and Jß2.7 gene segments, with a CDR3 that is characterized by a triad of amino acids, DWG, preceded by a polar residue. In addition, we used CDR3 length spectratyping, CDR3-specific reverse transcriptase–PCR and direct TcR sequencing to show that the TcR ß chain structural patterns associated with p530-specific T cells consistently appeared in the islets of young NOD mice with insulitis, but not in the inflamed islets of streptozotocin-treated C57BL/6 mice, or in inflamed NOD salivary glands. To our knowledge, this is the first report to demonstrate that a public T cell repertoire is used in spontaneous autoimmunity to a dominant self-determinant. These findings suggest that defined clonotypes and repertoires may be preferentially selected in haplotypes predisposed to spontaneous autoimmunity.

Keywords: autoimmunity, diabetes, gene rearrangements, NOD, TcR

Transmitting editor: R. Flavell


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
A. L. Furmanski, C. Ferreira, I. Bartok, S. Dimakou, J. Rice, F. K. Stevenson, M. M. Millrain, E. Simpson, and J. Dyson
Public T Cell Receptor -Chains Are Not Advantaged during Positive Selection
J. Immunol., January 15, 2008; 180(2): 1029 - 1039.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.